Management of hydrocephalus in infancy: Use of acetazolamide and furosemide to avoid cerebrospinal fluid shunts

Shlomo Shinnar, Karen Gammon, Eldo W. Bergman, Melvin Epstein, John M. Freeman

Research output: Contribution to journalArticlepeer-review

65 Scopus citations

Abstract

Despite its effectiveness, cerebrospinal shunting for hydrocephalus continues to be accompanied by considerable complications and morbidity. Medical therapy with acetazolamide 100 mg/kg/day and furosemide 1 mg/kg/day can be an effective alteraative to shunting by halting progression of hydrocephalus until such time as sutures can become fibrosed and spontaneous arrest can occur. In an appropriately selected population older than 2 weeks with hydrocephalus of varied origin, our success rate in avoiding shunting is >50%. The dramatic difference between the number of hospitalizations of patients with shunts and those treated medically, and the potential to avoid shunt dependence would appear to make an initial trial with medical therapy worthwhile.

Original languageEnglish (US)
Pages (from-to)31-37
Number of pages7
JournalThe Journal of Pediatrics
Volume107
Issue number1
DOIs
StatePublished - Jul 1985
Externally publishedYes

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health

Fingerprint Dive into the research topics of 'Management of hydrocephalus in infancy: Use of acetazolamide and furosemide to avoid cerebrospinal fluid shunts'. Together they form a unique fingerprint.

Cite this